Diploma PLC (LON:DPLM – Get Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 2,931.81 ($37.03) and traded as high as GBX 3,180 ($40.16). Diploma shares last traded at GBX 3,148 ($39.76), with a volume of 126,227 shares.
Analysts Set New Price Targets
A number of analysts recently weighed in on the stock. JPMorgan Chase & Co. raised their price target on shares of Diploma from GBX 2,400 ($30.31) to GBX 2,550 ($32.21) and gave the company an “underweight” rating in a report on Monday, July 17th. Shore Capital reissued a “buy” rating on shares of Diploma in a report on Wednesday, May 24th. Barclays reissued an “overweight” rating and issued a GBX 3,400 ($42.94) price target on shares of Diploma in a report on Tuesday, May 16th. Finally, Berenberg Bank raised their price target on shares of Diploma from GBX 3,360 ($42.43) to GBX 3,500 ($44.20) and gave the company a “buy” rating in a report on Wednesday, July 19th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, Diploma currently has an average rating of “Hold” and a consensus target price of GBX 2,985.71 ($37.71).
Diploma Trading Up 0.1 %
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, rest of Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies clinical diagnostics instrumentation and products, instrumentation and consumables, specialty surgical devices, and related consumables and services to public hospitals, private clinics, pathology laboratories, scientific research, and medical segments; surgical equipment for hospital operating rooms; and distributes laboratory diagnostics, specialty medical devices, devices, equipment, and patient monitoring technologies used in operating theatres, as well as medically supervised nutrition.
- Five stocks we like better than Diploma
- How to Invest in EV Charging Stations
- The Best 5 Small Cap AI Companies to Buy Now
- What are stock market earnings reports?
- Miso Robotics Stock: Is an IPO Coming Soon?
- Profitably Trade Stocks at 52-Week Highs
- 3 Stocks to Play the Easing Food Supply Chain
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.